VELIPARIB vs VENETOCLAX: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
VELIPARIB vs VENETOCLAX: Safety Overview
| Metric | VELIPARIB | VENETOCLAX |
|---|---|---|
| Total FAERS Reports | 391 | 53,724 |
| Deaths Reported | 43 | 15,763 |
| Death Rate | 11.0% | 29.3% |
| Hospitalizations | 222 | 20,812 |
| Average Patient Age | 57.9 yrs | 67.9 yrs |
| % Female Patients | 92.3% | 37.6% |
| FDA Approval Date | N/A | Apr 11, 2016 |
| Manufacturer | N/A | AbbVie Inc. |
| Route | N/A | ORAL |
| Marketing Status | N/A | Prescription |